Journal article

Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases

Alaa MG Ali, Marjanka K Schmidt, Manjeet K Bolla, Qin Wang, M Gago-Dominguez, J Esteban Castelao, Angel Carracedo, Victor Munoz Garzon, Stig E Bojesen, Borge G Nordestgaard, Henrik Flyger, Jenny Chang-Claude, Alina Vrieling, Anja Rudolph, Petra Seibold, Heli Nevanlinna, Taru A Muranen, Kirsimari Aaltonen, Carl Blomqvist, Keitaro Matsuo Show all

Cancer Epidemiology Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2014

Grants

Awarded by Cancer Research UK


Awarded by Dutch Cancer Society


Awarded by BBMRI-NL


Awarded by Deutsche Krebshilfe e.V.


Awarded by European Community's Seventh Framework Programme


Awarded by FIS Intrasalud


Awarded by Health Strategic Action Instituto de Salud Carlos III


Awarded by Academy of Finland


Awarded by NIH


Awarded by Lon V Smith Foundation


Awarded by United States National Cancer Institute, NIH


Awarded by NATIONAL CANCER INSTITUTE


Awarded by The Francis Crick Institute


Funding Acknowledgements

A.M.G. Ali was supported by a studentship from the Citadel Capital Foundation, Egypt. M. Garcia-Closas was funded by the Breakthrough Breast Cancer Research Centre, London, United Kingdom. J.L. Hopper is a National Health and Medical Research Council (NHMRC) Australia Fellow and a Victorian Breast Cancer Research Consortium Group Leader.Funding of the constituent studies was provided by the Botin Foundation Fund; Cancer Research UK (C490/A10119, C490/A10124, C1287/A10118 and C1287/A12014); the Dutch Cancer Society (NKI-2007-3839; NKI-2009-4363); BBMRI-NL (NWO 184.021.007); Dutch Ministry of Public Health; Welfare and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, Zorg Onderzoek Nederland; World Cancer Research Fund, Statistics Netherlands; the Dutch National Genomics Initiative; the Deutsche Krebshilfe e.V. (70492); European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175); FIS Intrasalud (PS09/02368); Grant-in-Aid for Scientific Research on Priority Areas and on Innovative Area, Ministry of Education, Science, Sports, Culture and Technology of Japan; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control, Ministry of Health, Labour and Welfare, Japan; Health Strategic Action Instituto de Salud Carlos III (FIS PI12/02125); the Hellenic Health Foundation (Greece); the Helsinki University Central Hospital Research Fund, the Academy of Finland (132473), Norwegian Research Council and Norwegian Cancer Society; the Sigrid Juselius Foundation, the Finnish Cancer Society; Herlev Hospital, the Danish Medical Research Council, Chief Physician Johan Boserup and Lise Boserup's Fund.; Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services; NIH (CA58860, CA92044) and the Lon V Smith Foundation (LVS39420); the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, Norwegian Research Council and Norwegian Cancer Society; the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium; the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; and the United States National Cancer Institute, NIH (RFA-CA06503, U01-CA69638, UM1-CA164920).